Receptors encompassing both CD28 and CD3ζ are the prototypes for second generation CARs, which are now rapidly expanding to a diverse array of receptors with different functional properties.
Second generation CARs, which are just now entering the clinical arena in the B cell malignancies and other cancers, will provide a more significant test for this approach.
The consequences of introducing additional costimulatory domains into second generation CARs have been directly compared against first generation configurations in subjects with B cell lymphomas who were infused with two autologous CD19-specific CAR-modified therapies.
Here, LV delivery of second generation CARs (with CD3ζ and 4-1BB domains) was combined with patient conditioning with combinations of cyclophosphamide, bendamustine, penotatsin and etoposide in patients with CLL and acute lymphoblastic leukaemia (ALL) (Kalos et al, 2011; Porter et al, 2011; Grupp et al, 2013).
Enblad, G. et al. CD19-targeting third generation CAR T cells for relapsed and refractory lymphoma and leukemia report from the Swedish phase I/IIa trial.
"I like the wheelbase and stance of the first generation car," explains Mark Stielow, 48, whose hobby is modifying 1967-1969 coupeslet Camaro coupes into Porsche-slaying supercars.
The fourth generation car is production-ready, according to GM's Dan Ammann, who discussed the new vehicle on a press call announcing the news today.
Their third generation car will be called, appropriately, the Model 3. (Which, if you ask me, is even more similar to Model T phonetically. Oh, and it's also not to be confused with the BMW 3 Series).
Herein, we used a third generation CAR against PSCA and we also show significant delay in tumor growth rate and significantly prolonged survival of nude mice.
